Compare ALPS & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ALPS | IGA |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.7M | 152.5M |
| IPO Year | N/A | N/A |
| Metric | ALPS | IGA |
|---|---|---|
| Price | $0.98 | $9.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.1K | ★ 61.9K |
| Earning Date | 07-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.56 | $9.21 |
| 52 Week High | $1.72 | $10.12 |
| Indicator | ALPS | IGA |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 56.52 |
| Support Level | $0.85 | $9.68 |
| Resistance Level | $1.02 | $9.89 |
| Average True Range (ATR) | 0.06 | 0.17 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 45.45 | 100.00 |
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.